Multi-strain Probiotics May Lower Endotoxin Levels and Cardiometabolic Markers in Diabetics
Could probiotics decrease endotoxin levels and other cardiometabolic parameters in patients with type 2 diabetes mellitus (T2DM)? This study set out to assess whether multi-strain probiotic supplementation could reduce endotoxin levels and consequently improve cardiometabolic profiles in metabolically-high risk populations. This 6-month, single-center, double-blind, randomized, placebo-controlled clinical trial included 150Read
